I thought that some may find the study below interesting. It addresses
concerns that some have asked about in the past. It is also fairly
recent, 2008, and makes the following statements. 

" Unlike pharmaceutical antibiotics, which destroy
beneficial enzymes, colloidal silver leaves these beneficial
enzymes intact (Hall et al., 1999). An added advantage
to the use of silver is that it has variously been
shown to have high safety profile in vivo and cannot
interact or interfere with other medicines being taken
(Iroha et al., 2007). Furthermore, it is known not to
destroy the normal microbial flora of the gut thereby
avoiding the negative effects of traditional antibiotics that
kill good bacteria in the lower digestive tract (Beaker and
Spadaro, 1981)."  

More below.

 - Steve N


http://www.academicjournals.org/sre/PDF/pdf2008/May/Iroha%20et%20al%20.p
df

In vitro evaluation of the activity of colloidal silver
concentrate against Pseudomonas aeruginosa isolated
from postoperative wound infection

"RESULTS AND DISCUSSION
The result of sensitivity studies (Table 1) shows that P.
aeruginosa was susceptible to antimicrobial action of
colloidal silver concentrate. The MIC results (Table 2) of
colloidal silver reveals that the test organisms were
susceptible within the ranges of 0.078 to 0.313 ug/ml.
The killing rate studies showed that the population of P.
aeruginosa was drastically reduced to non- existing level
at the 90th min (Figure 1). The first order killing rate
constant was estimated to be 0.084 min-1. This
demonstrates that colloidal silver has an antibacterial
activity against P. aeruginosa.
The rate at which microorganism develops resistance
to conventional antimicrobial agents posses a serious
public health problem globally. P. aeruginosa is known to
be resistant to many antimicrobial agents and has been
implicated in post operative wound infections (Oguntibeju
and Nwobu, 2004). Faced with the challenge of
increasing incidence of infections caused by P.
aeruginosa and its resistance problem, an attempt was
made to establish the in vitro antibacterial activity of
colloidal silver concentrate in our environment.

Colloidal silver is one agent that has a tremendous
antimicrobial effect and has been used successfully in the
treatment of many infectious diseases without visible side
effect (Wickless and Schwader, 2004). Our study has
further confirmed the potent antibacterial activity of
colloidal silver concentrate against P. aeruginosa. This
presents a clear indication for the potential applicability of
colloidal silver in the treatment of some post operative
wound infections caused by this organism. Presently, the
use of colloidal silver in the treatment of various infectious
diseases is growing exponentially. It has been
shown that its presence near a virus, fungi, bacteria or
any other single cell pathogen disables its oxygen metabolizing
enzymes, and within a few minutes the pathogen
suffocates, dies and is cleared out of the body by the
immune lymphatic and elimination system (Hall et al.,
1999). Unlike pharmaceutical antibiotics, which destroy
beneficial enzymes, colloidal silver leaves these beneficial
enzymes intact (Hall et al., 1999). An added advantage
to the use of silver is that it has variously been
shown to have high safety profile in vivo and cannot
interact or interfere with other medicines being taken
(Iroha et al., 2007). Furthermore, it is known not to
destroy the normal microbial flora of the gut thereby
avoiding the negative effects of traditional antibiotics that
kill good bacteria in the lower digestive tract (Beaker and
Spadaro, 1981).
The result from Figure 1 showed that the killing potency
of colloidal silver is very high, killing a given population of
P. aeruginosa within 90 min. This could be attributed to
its small particle size that increases its surface area,
which enables it to penetrate the organism's cell membrane.
Also, the ionic (positive charge) nature is considered
the primary benefiting feature of colloidal silver
being able to aggressively attach to microbial cells and
kill them (Hall et al., 1999). In the present study, colloidal
silver was shown to demonstrate very potent antibacterial
activity against P. aeruginosa isolated from post operative
eye infection. This activity should be urgently explo-
red in the development of highly active antibacterial
therapeutic agents to combat the rapidly increasing
infectious diseases that currently challenge the present
arsenal of antibacterial drugs."


--
The Silver List is a moderated forum for discussing Colloidal Silver.
  Rules and Instructions: http://www.silverlist.org

Unsubscribe:
  <mailto:[email protected]?subject=unsubscribe>
Archives:
  http://www.mail-archive.com/[email protected]/maillist.html

Off-Topic discussions: <mailto:[email protected]>
List Owner: Mike Devour <mailto:[email protected]>